AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Massachusetts

S1009

Relative to plant medicine

Status

Did not pass; died when the session ended

2024 Session

IntroducedFeb 16, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Patricia Jehlen (Democrat)
Type: Study/Task Force
Substances: Psilocybin

Official text

Summary (from PoliPsy)

For legislation relative to plant medicine. The Judiciary.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: malegislature.gov

Legislative history

July 30, 2024
Accompanied a study order, see S2926
February 16, 2023
Referred
February 16, 2023
Introduced

Loading bill…